Pre-operative serum level of tumour-associated trypsin inhibitor and residual turnour size as prognostic indicators in stage III epithelial ovarian cancer

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 105, Issue 5, 1998, Pages 508-511

  Venesmaa, Pekka ^a   Stenman, Ulf Håkan ^a   Forss, Matti ^a   Leminen, Arto ^a   Lehtovirta, Pentti ^a   Vartiainen, Juhani ^a   Paavonen, Jorma ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; CA 125 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; TUMOR MARKER;

ADULT; AGE; AGED; ARTICLE; BLOOD LEVEL; CANCER CLASSIFICATION; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; RADIOIMMUNOASSAY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM, RESIDUAL; OVARIAN NEOPLASMS; PREOPERATIVE CARE; RADIOIMMUNOASSAY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; SURVIVAL RATE; TRYPSIN INHIBITORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0031838820     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1998.tb10150.x     Document Type: Article

References (16)

1. Bertelsen K. Tumor reduction surgery and long-term survival in advanced ovarian cancer: a DACOVA study. Gynecol Oncol 1990; 38: 203–209.
2. Makar AP, Kristensen GB, Kaem J, Bormer OP, Abeler VM, Trope CG. Prognostic value of pre- and postoperative serum CA 125 levels in ovarian cancer: new aspects and multivariate analysis. Obstet Gynecol 1992; 79: 1002–1010.
3. Venesmaa P, Lehtovirta P, Stenman U-H, Leminen A, Forss M, Ylikorkala O. Tumor-associated trypsin inhibitor (TATI): Comparison with CA 125 as a preoperative prognostic indicator in advanced ovarian cancer. Br J Cancer 1994; 70: 1188–1190.
4. Stenman U-H, Huhtala M-L, Koistinen R, Seppälä M. Immunochemical demonstration of an ovarian cancer-associated urinary peptide. Int J Cancer 1982; 30: 53–57.
5. Halila H, Lehtovirta P, Stenman U-H. Tumour-associated trypsin inhibitor in ovarian cancer. Br J Cancer 1988; 57: 304–307.
6. Dixon WJ. BMDP Statistical Software. Berkeley University of California Press: 1981.
7. Pettersson, F (editor). Annual report on the results of treatment in gyne-cological cancer, FIGO. 1994, Stockholm, Sweden, 1995, p 278.
8. Stenman U-H, Koivunen E, Itkonen O. Biology and function of tumor-associated trypsin inhibitor, TATI. Scand J Clin Lab Invest 1991; 51: (Suppl 207): 5–9.
9. Koivunen E, Huhtala M-L, Stenman U-H. Human ovarian tumor-associated trypsin. Its purification from mucinous cyst fluid and identification as anactivator of pro-urokinase. J Biol Chem 1989; 264: 1409–14099.
10. Koivunen E, Ristimäki A, Itkonen O, Osman S, Vuento, M, Stenman, U-H. Tumor-associated trypsin participates in cancer cell-mediated degradation of extracellular matrix. Cancer Res 1991; 51: 2107–2112.
11. Van der Burg MEL, Lammes FB, van Putten WLJ, Stoter G. Ovarian cancer: the prognostic value of the serum half-life of CA125 during induction chemotherapy. Gynecol Oncol 1988; 30: 307–312.
12. Lavin PT, Knapp RC, Malkasian GD, Whitney C, Berek JS, Bast RC. CA125 for the monitoring of ovarian carcinoma during primary therapy. Obstet Gynecol 1987; 69: 223–227.
13. McGuire WP, Hoskins WJ, Brady MF et al. Cyclophosphamide and cis-platin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 1996; 334: 1–6.
14. Halila H, Huhtala ML, Haglund C, Nordling S, Stenman U-H. Tumour-associated trypsin inhibitor (TATI) in human ovarian cyst fluid. Comparison with CA125 and CEA. Br J Cancer 1987; 56: 153–156.
15. Autio-Harmainen H, Karttunen T, Hurskainen T, Höyhtyä M, Kauppila A, Tryggvason K. Expression of 72 kilodalton type IV collagenase (gelatinase A) in benign and malignant ovarian tumors. Lab Invest 1993; 69: 312–321.
16. Sorsa T, Salo T, Koivunen E et al. Activation of type IV procollagenases by human tumor-associated trypsin-2. J Biol Chem 1997; 272: 21067–21074.